The same technology used in Moderna’s COVID-19 vaccines is now being used to fight the flu. On Aug. 5, the FDA approved ...
Roivant Sciences is transitioning from an asset-monetization platform to a commercial-stage biopharma. Check out why ROIV ...
The first mRNA flu vaccine is expected to arrive for the 2026-27 season, giving older adults another option alongside ...
Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...
FDA clears Moderna's first mRNA flu vaccine for adults 50+, showing 27% higher efficacy than standard shots, ahead of the ...
Sara Hassan is a Digital Editor/Reporter at The World. She has more than two decades of journalism experience, as a writer, photographer, copy editor, reporter and field producer for TV, radio, ...
It is the first flu vaccine that uses mRNA technology, similar to Pfizer and Moderna's COVID vaccines.
The Food and Drug Administration this week approved the first mRNA flu vaccine for adults 50 and older. Health experts lauded ...
The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva. The vaccine is ...
At any given time, somewhere in the world, it’s flu season. One of humanity’s oldest infectious scourges, influenza has ...
Moderna’s mFLUSIVA is the first FDA-approved influenza vaccine using mRNA technology and is expected to be available for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results